logo
ResearchBunny Logo
A Self-Assembling Mosaic Nanoparticle Vaccine for Broad Coronavirus Immunity

Medicine and Health

A Self-Assembling Mosaic Nanoparticle Vaccine for Broad Coronavirus Immunity

P. Bjorkman

This groundbreaking study by Pamela Bjorkman explores a novel mosaic nanoparticle vaccine, 6RBD-np, designed to deliver six receptor-binding domains from coronaviruses. The research showcases its ability to induce high antibody responses and complete protection against SARS-CoV-2 variants, paving the way for a potential broad-spectrum coronavirus vaccine.

00:00
00:00
Playback language: English
Abstract
The study introduces a novel mosaic nanoparticle vaccine (6RBD-np) utilizing a self-assembling heterotrimeric proliferating cell nuclear antigen (PCNA) scaffold to deliver six receptor-binding domains (RBDs) from α- and β-coronaviruses. This approach addresses limitations of existing mosaic nanoparticle platforms by ensuring uniform antigen distribution. In mice, 6RBD-np elicited high antibody titers against multiple coronaviruses and conferred complete protection against SARS-CoV-2 WT and Delta variants, demonstrating its potential as a broad-spectrum coronavirus vaccine.
Publisher
PNAS
Published On
Jan 01, 2023
Authors
Pamela Bjorkman
Tags
mosaic nanoparticle vaccine
coronavirus
self-assembling PCNA scaffold
antibody response
SARS-CoV-2
protection
RBDs
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny